Revvity | PKI - 销售成本



金融业
股票价格
USD
资产
USD 12.05B
现金及等价物
USD 1.02B
销售成本
USD 312.82M
流动资产
USD 2.3B
流动负债
USD 1.28B
债务
USD 3.35B
股息收益率
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
员工
11K
EPS每股收益
USD 1.41
股本和储备
USD 7.18B
销售毛利
USD 416.87M
债务利息支出
USD 22.99M
利息收入
USD 6.3M
贷款资金
USD 2.63B
市值
USD 14.11B
净收入
USD 51.82M
营业费用
USD 603.55M
营业利润
USD 126.14M
普通股股本
USD 111.63M
PE价格收益
36.47
税前利润
USD 187.24M
销售收入
USD 729.68M
销售和管理费用
USD 278.58M
股票
USD 378.5M
贸易债权人
USD 165.74M
应收帐款人
USD 709.18M


销售成本 更改 日
Agilent USD 845M 7M 2026-03
Align Technology USD 298.76M 4.74M 2026-06
Bio Techne USD 103.13M 1.47M 2026-03
Bio-Rad Laboratories USD 305.2M 22.5M 2026-06
Bruker USD 422.5M 21.1M 2026-06
Celltrion KRW 92.83B 14.59B 2026-03
Charles River Laboratories USD 655.29M 61.22M 2026-06
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
Danaher USD 2.65B 294M 2026-06
Dentsply International USD 405M 48M 2026-06
Deva Holding AS TRY 991.13M 182.81M 2023-09
Divis Laboratories Ltd INR 11.19B 1.2B 2026-06
Edwards Lifesciences USD 392.4M 29.8M 2026-06
Illumina USD 389M 19M 2026-06
Intuitive Surgical USD 931.9M 8.4M 2026-06
IQVIA Holdings USD 3.22B 141M 2026-06
Kangmei Pharma CNY 841.45M 271.27M 2026-03
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Laboratory Of America USD 2.7B 97.8M 2026-06
Medical Developments International AUD 7.09M 4.91M 2025-12
Mesa Laboratories USD 21.92M 1.78M 2024-09
Mettler Toledo International USD 396.52M 14.4M 2026-06
Myriad Genetics USD 63M 1.1M 2025-12
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
OraSure Technologies USD 15.43M 113K 2025-12
Organigram Holdings CAD 43.39M 13.54M 2026-03
Pacific Biosciences Of California USD 28.9M 10M 2025-12
Pharma Mar EUR 4.73M 1.08M 2026-06
Qiagen NV USD 182.72M 34.71M 2026-03
Quest Diagnostics USD 2.05B 64M 2026-06
Quidel USD 407M 486.5M 2026-06
Repligen USD 94.09M 8.12M 2026-06
Revvity USD 312.82M 10.64M 2026-06
Sartorius EUR 478.7M 5.9M 2026-06
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Thermo Fisher Scientific USD 7.54B 577M 2026-06
Tilray USD 164.37M 8.41M 2025-09
Waters USD 1.16B 430M 2026-06
Zealand Pharma A/S 410K 5K 2025-06
Zz Pientze Pharmaceu CNY 1.58B 245.15M 2026-03